Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

NCT06814574 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-02-07

No results posted yet for this study

Summary

Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.

Conditions

  • AV Block Complete
  • Tricuspid Regurgitation (TR)

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06814574 on ClinicalTrials.gov